Advances in understanding the pathogenesis of congenital erythropoietic porphyria.

Abstract excerpt

Congenital erythropoietic porphyria (CEP) is a rare genetic disease resulting from the remarkable deficient activity of uroporphyrinogen III synthase, the fourth enzyme of the haem biosynthetic pathway. This enzyme defect results in overproduction of the non-physiological and pathogenic porphyrin isomers, uroporphyrin I and coproporphyrin I. The predominant clinical characteristics of CEP include bullous...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to GATA1 Transcription Factor
• Share to ALAS2 gene
• Share to GATA1 gene